Men diagnosed at this hospital trust can access the following services (updated 2019):

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Whole body MRI
• Isotope bone scan

• Treatment Facilities:
• Robot assisted laparoscopic prostatectomy
• External beam radiotherapy
• Intensity-modulated radiotherapy
• Low-dose rate brachytherapy
• Stereotactic body radiation therapy (SBRT)
• Chemotherapy
• Joint specialist MDT clinic

• Support Service Facilities:
• Prostate cancer clinical nurse specialist (PCa CNS)
• Advanced PCa CNS
• Sexual function services
• Specialist continence services
• Psychological counselling

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	171	1349
Performance Status recorded	42%	46%
PSA completed	51%	61%
Gleason Score completed	91%	88%
TNM completed	83%	79%
Risk group assigned	89%	87%

	Specialist MDT	National
No. of men with disease status determined	1203	49027
Percentage of men diagnosed with metastatic disease	10%	13%

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	60	3055
Percentage of men with low-risk localised disease receiving radical treatment	2%	5%
No. of men diagnosed with locally advanced disease	444	19663
Percentage of men diagnosed with locally advanced disease receiving radical treatment	76%	71%
No. of men diagnosed with M1 (metastases)	126	6136
Percentage of men diagnosed with M1 (metastases) receiving docetaxel	33%	36%

	Specialist MDT	National
No. of men diagnosed 1st April 18 - 30th Sept 18 who had radical treatment (surgery or radiotherapy) and were sent a questionnaire	294	10750
Percentage of men who responded	70%	78%
No. of men who completed CNS question	199	8137
Percentage of men who were ‘given the name of a CNS’	88%	87%
No. of men who rated their overall care on a scale of 1-10	194	7878
Percentage of men who rated their overall care as 8 or above	91%	91%

	Treatment Centre
No. of men who received radical prostatectomy (2018-2019)	218
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	10%
No. of men who received radical prostatectomy (2017)	150
Adjusted percentage of men experiencing at least one GU complication requiring a procedural/surgical intervention (%)	10%
No. of men who received radical radiotherapy (2017)	295
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%)	12%

	Treatment Centre
No. of men diagnosed 1st April 18 - 30th Sept 18 who received radical prostatectomy and were sent a questionnaire	66
Percentage of men who responded	80%
No. of men who completed sufficient information for a validated EPIC-26 urinary incontinence score to be determined	52
Adjusted EPIC-26 urinary incontinence score (0=worst to 100=best)	79
No. of men who completed sufficient information for a validated EPIC-26 sexual function score to be determined	52
Adjusted EPIC-26 sexual function score (0=worst to 100=best)	30
No. of men diagnosed 1st April 18 - 30th Sept 18 who received external beam radiotherapy and were sent a questionnaire	188
Percentage of men who responded	71%
No. of men who completed sufficient information for a validated EPIC-26 bowel function score to be determined	119
Adjusted EPIC-26 bowel function score (0=worst to 100=best)	88
No. of men who completed sufficient information for a validated EPIC-26 sexual function score to be determined	123
Adjusted EPIC-26 sexual function score (0=worst to 100=best)	21